NARSAD
Welcome, guest
[login or register]
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Patricio O’Donnell, M.D., Ph.D. (Independent Investigator 2003) of Albany Medical College, notes that schizophrenia is a disorder affecting several brain regions, and has been studying how these different regions interact in normal animals, gaining insight on how alterations in some (e.g., the hippocampus) can result in deficits on others (e.g. the dopamine pathways). He now wants to address how interactions among areas involved in schizophrenia are affected in animal models that include a developmental component. A previous model is the neonatal ventral hippocampal lesion, in which behavioral anomalies emerge only after puberty. He has shown that neurons in the prefrontal cortex and nucleus accumbens exhibit an abnormal response to the activation of dopamine projections, which are blocked with subchronic pretreatment with haloperidol. Though the model mimics schizophrenia in the time delay in symptom emergence and the system affected (dopamine) and is reversed by an antipsychotic, it involves a lesion in the hippocampus which schizophrenia patients do not have. Dr. O’Donnell recently modified the model with a transient neonatal inactivation instead of a lesion by injecting a compound that blocks neural activity (tetrodotoxin, TTX; a blocker of ion channels involved in nerve conduction that does not kill neurons). It has been shown to elicit similar behavioral changes to those observed with the lesion. He will now further study this non-lesion model to determine if the results are similar to what was observed with a lesion model. If so, the transient inactivation may prove a useful and more valid model. Such a model could be a useful tool to test new antipsychotic drugs.

Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Independent Investigator application deadline: March 5, 2008

2008 Young Investigator, 2008 Distinguished Investigator and 2008 Staglin Grantees Announced: March, 2008

2008 Distinguished Investigator Earliest Start Date: May 1, 2008

2009 Distinguished Investigator Award application deadline: May 15, 2008

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award application deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Award Earliest Start Date: September 15, 2008

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009





NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us